Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nandrolone for ICU-acquired weakness after prolonged critical illness
ACTRN12616000835448Phase 2Completed
- Sponsor
- Sir Charles Gairdner Hospital
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute quadriplegic myopathy (CIM) and Malnutrition comparing Nandrolone with Placebo (2 arms). Primary endpoints: Change in grip strength, Change in Medical Research Council muscle strength sum score and 1 more. Started Oct 2017; status: completed.
02
Drugs
nandrolone
03
Conditions
acute quadriplegic myopathy (CIM)Malnutrition
Beyond the preview
Go deeper on ACTRN12616000835448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000835448.